Your browser doesn't support javascript.
loading
Vaccine design and delivery approaches for COVID-19.
Shahzamani, Kiana; Mahmoudian, Fatemeh; Ahangarzadeh, Shahrzad; Ranjbar, Mohammad Mehdi; Beikmohammadi, Leila; Bahrami, Samira; Mohammadi, Elmira; Esfandyari, Sahar; Alibakhshi, Abbas; Javanmard, Shaghayegh Haghjooy.
Afiliación
  • Shahzamani K; Isfahan Gastroenterology and Hepatology Research Center (lGHRC), Isfahan University of Medical Sciences, Isfahan, Iran.
  • Mahmoudian F; Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahangarzadeh S; Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Ranjbar MM; Razi Vaccine and Serum Research Institute, Agricultural Research, Education, and Extension Organization (AREEO), Karaj, Iran.
  • Beikmohammadi L; Department of Biochemistry, Erasmus University Medical Center, Rotterdam, the Netherlands; Stem Cell and Regenerative Medicine Center of Excellence, Tehran University of Medical Sciences, 14155-6559 Tehran, Iran.
  • Bahrami S; Biotechnology Department, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Mohammadi E; Applied Physiology Research Center, Cardiovascular Research Institute, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran; Core Research Facilities, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Esfandyari S; Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Alibakhshi A; Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: alibakhshi2630@yahoo.com.
  • Javanmard SH; Applied Physiology Research Center, Cardiovascular Research Institute, Department of Physiology, Isfahan University of Medical Sciences, Isfahan, Iran. Electronic address: sh_haghjoo@med.mui.ac.ir.
Int Immunopharmacol ; 100: 108086, 2021 Nov.
Article en En | MEDLINE | ID: mdl-34454291
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Irán
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 4_TD Problema de salud: 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 4_pneumonia Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Humans Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Irán